Health ❯ Healthcare ❯ Pharmaceuticals

Generic Drugs

Drug Shortages Semaglutide Atorvastatin Calcium Drug Pricing Lisdexamfetamine Dimesylate Viatris Liraglutide Safety Concerns Weight Loss Medications CivicaScript

India Rolls Out Low-Cost Semaglutide Generics After Patent Expiry

Patent protections in the United States and Europe extend into the next decade to delay generic entry.

FDA Class II Recall Targets Generic Vyvanse After Dissolution Failures

FDA Class II Recall Issued for 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

FDA Class II Recall Targets 142,000 Bottles of Ascend’s Atorvastatin

Delhi High Court Rejects Roche Appeal, Clears Natco’s ₹15,900 Generic Risdiplam

UK ‘Postcode Lottery’ for Weight-Loss Jabs Persists as Generics Line Up for 2026

Hims & Hers Plans Canadian Launch of Generic Semaglutide After Zava Acquisition

Over 32,000 Boxes of Lisinopril Recalled in France Over Labeling Error